InhibOx develops and applies novel and effective computational methods to improve the productivity of drug discovery. The InhibOx discovery pipeline focuses on the delivery of novel antibiotics for the treatment of drug-resistant bacterial infections.
| Website | http://www.inhibox.com |
| Revenue | $200000 |
| Employees | View employees |
| Founded | 2001 |
| Phone | +44 1865 261471 |
| Technologies |
JavaScript
,
HTML
,
PHP
+17 more
(view full list)
|
| Industry | Biotechnology, Pharmaceuticals, Healthcare |
| Competitors | Merck Group, Thermo Fisher Scientific, Genentech, Bristol Myers Squibb, Pfizer, Roche, GSK, Novartis, Biogen, AstraZeneca +35 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular InhibOx employee's phone or email?
InhibOx Questions
The InhibOx annual revenue was $200000 in 2026.
The NAICS codes for InhibOx are [325, 32, 3254].
The SIC codes for InhibOx are [283, 28].
Related Companies
G2Crowd Trusted
300K+
Plugin Users
